Komori
Haba Laboratories (4925) · FactAdvancedLatest Results (2026-11-13): "Worsened"

Return to revenue and profit growth and expansion of sales centered on basic skincare products

First written in FY2017-Q2. 16 of 36 entries say "Worsened", first in FY2020-Q3. Latest entry: 2026-11-13.

36entries
11years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2017-Q3 – FY2020-Q2WorsenedFY2020-Q3 – FY2022OtherFY2024-Q3 – FY2026-H12016: 12017: 320172018: 420182019: 420192020: 420202021: 420212022: 420222023: 420232024: 320242025: 220252026: 32026
Same theme, other companies
Operating, ordinary and parent-company profit turning profitable amid higher revenueA theme 4 companies write about · 0 as a headwind · 4 as a tailwind

Haba Laboratories moved to the "Worse" side of this theme in 2020.

2 other companies' latest entry also says "Worsened".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「For the fiscal year, the Group's consolidated net sales were ¥12,141.299 million, up 0.7% from the previous fiscal year. As a result, operating income was ¥727.365 million, up 23.4%; ordinary income was ¥708.204 million, up 16.3%; and net income attributable to owners of the parent was ¥760.360 million, up 31.9%.」

    For the full year, net sales returned to growth, while operating income, ordinary income and net income also increased. Profit recovery through reform of the earnings structure progressed in the full-year results.
  2. FY2026-H1Revenue Growth and Return to ProfitabilityAnnual report

    「Against this economic backdrop, the Group's consolidated net sales for the interim consolidated accounting period were ¥5,550.795 million, up 1.7% year on year.」

    Net sales increased 1.7% year on year, while operating income was ¥257.593 million, ordinary income was ¥252.097 million and interim net income attributable to owners of the parent was ¥187.976 million. The company shifted from operating, ordinary and net losses in the same period of the previous year to interim profitability accompanied by higher sales.
  3. FY2025From lower revenue to a return to profitabilityAnnual report

    「The fiscal year resulted in lower sales and higher profits. As a result, operating income was ¥589.510 million, compared with an operating loss of ¥187.769 million in the previous fiscal year; ordinary income was ¥608.993 million, compared with an ordinary loss of ¥191.493 million; and net income attributable to owners of the parent was ¥576.566 million, compared with a net loss attributable to owners of the parent of ¥2,118.627 million.」

    Net sales declined 2.1% from the previous fiscal year, but operating income, ordinary income and net income all returned to profitability. This represents a recovery in profits accompanied by lower sales, rather than a complete shift to higher sales and profits.
  4. FY2025-H1Continued decline in sales and narrowing lossAnnual report

    「As a result, the company posted an operating loss of ¥36.739 million, compared with an operating loss of ¥464.317 million in the same period of the previous year; an ordinary loss of ¥22.582 million, compared with an ordinary loss of ¥463.047 million; and an interim net loss attributable to owners of the parent of ¥15.613 million, compared with an interim net loss attributable to owners of the parent of ¥345.357 million.」

    Net sales were ¥5,455.967 million, down 1.3% year on year, while the operating loss, ordinary loss and interim net loss all narrowed substantially from the same period of the previous year. Progress in measures to improve the earnings structure is described as having reduced the losses.
  5. FY2024Narrower operating loss and larger net lossAnnual report

    「As a result, the company posted an operating loss of ¥187.769 million, compared with an operating loss of ¥609.642 million in the previous fiscal year; an ordinary loss of ¥191.493 million, compared with an ordinary loss of ¥582.623 million; and a net loss attributable to owners of the parent of ¥2,118.627 million, compared with a net loss attributable to owners of the parent of ¥707.865 million.」

    Net sales increased 2.4% from the previous fiscal year, and the operating and ordinary losses narrowed, while the net loss attributable to owners of the parent expanded due to impairment losses and other items totaling ¥1,576.370 million.
  6. FY2024-Q3Narrower operating loss and larger net lossAnnual report

    「As a result, the company posted an operating loss of ¥573.321 million, compared with an operating loss of ¥767.927 million in the same quarter of the previous year; an ordinary loss of ¥573.569 million, compared with an ordinary loss of ¥742.740 million; and a quarterly net loss attributable to owners of the parent of ¥912.006 million, compared with a quarterly net loss attributable to owners of the parent of ¥810.744 million in the same quarter of the previous year, due to the reversal of deferred tax assets.」

    While net sales declined 1.1% year on year, the operating and ordinary losses narrowed. However, the quarterly net loss attributable to owners of the parent expanded due to the reversal of deferred tax assets.
  7. FY2024-Q2WorsenedAnnual report

    「For the cumulative second quarter, the Group's consolidated net sales were ¥5,527.019 million, down 2.2% from the same quarter of the previous year. As a result, the company posted an operating loss of ¥464.317 million, compared with an operating loss of ¥346.669 million in the same quarter of the previous year; an ordinary loss of ¥463.047 million, compared with an operating loss of ¥324.420 million; and a quarterly net loss attributable to owners of the parent of ¥345.357 million, compared with a quarterly net loss attributable to owners of the parent of ¥230.748 million.」

    Net sales declined year on year, while the operating loss, ordinary loss and quarterly net loss attributable to owners of the parent expanded. The operating margin also declined from -6.1% to -8.4%, indicating further deterioration in earnings conditions.
  8. FY2024-Q1WorsenedAnnual report

    「As a result, the company posted an operating loss of ¥290.934 million, compared with an operating loss of ¥212.472 million in the same quarter of the previous year; an ordinary loss of ¥288.217 million, compared with an ordinary loss of ¥212.896 million; and an income taxes adjustments amount of -¥98.783 million, resulting in a quarterly net loss attributable to owners of the parent of ¥215.050 million, compared with a quarterly net loss attributable to owners of the parent of ¥140.692 million.」

    The operating loss, ordinary loss and quarterly net loss attributable to owners of the parent all expanded from the same quarter of the previous year, and earnings conditions deteriorated. Net sales were also ¥2,569.673 million, down 7.8% year on year.
  9. FY2023WorsenedAnnual report

    「Under these circumstances, the Group's consolidated net sales for the fiscal year were ¥12,038.052 million, down 6.7% from the previous fiscal year. As a result, the company posted an operating loss of ¥609.642 million, compared with an operating loss of ¥316.730 million in the previous fiscal year; an ordinary loss of ¥582.623 million, compared with an operating loss of ¥292.579 million; and a net loss attributable to owners of the parent of ¥707.865 million, compared with a net loss attributable to owners of the parent of ¥269.030 million.」

    Full-year net sales were ¥12,038.05 million, down 6.7% from the previous fiscal year, while the operating loss was ¥609.642 million and the net loss attributable to owners of the parent was ¥707.865 million, with losses expanding from the previous fiscal year.
  10. FY2023-Q3WorsenedAnnual report

    「For the cumulative third quarter, the Group's consolidated net sales were ¥8,735.268 million, down 8.6% from the same quarter of the previous year. As a result, the company posted an operating loss of ¥767.927 million, compared with an operating loss of ¥505.010 million in the same quarter of the previous year; an ordinary loss of ¥742.740 million, compared with an ordinary loss of ¥480.865 million; and an income taxes adjustments amount of -¥16.623 million, resulting in a quarterly net loss attributable to owners of the parent of ¥810.744 million, compared with a quarterly net loss attributable to owners of the parent of ¥529.325 million.」

    Net sales declined 8.6% year on year, and the operating loss, ordinary loss and quarterly net loss attributable to owners of the parent all expanded. The operating margin also declined from -5.3% to -8.8%.
  11. FY2023-Q2Continued decline in sales and narrowing lossAnnual report

    「For the cumulative second quarter, the Group's consolidated net sales were ¥5,652.567 million, down 5.5% from the same quarter of the previous year. As a result, the company posted an operating loss of ¥346.669 million, compared with an operating loss of ¥568.334 million in the same quarter of the previous year; an ordinary loss of ¥324.420 million, compared with an ordinary loss of ¥568.014 million; and an income taxes adjustments amount of -¥118.556 million, resulting in a quarterly net loss attributable to owners of the parent of ¥230.748 million, compared with a quarterly net loss attributable to owners of the parent of ¥464.481 million.」

    While net sales continued to decline, down 5.5% from the same quarter of the previous year, the operating loss narrowed from ¥568.334 million to ¥346.669 million, and the quarterly net loss attributable to owners of the parent narrowed from ¥464.481 million to ¥230.748 million. The operating margin also improved by 3.4 percentage points, from -9.5% to -6.1%.
  12. FY2023-Q1Continued decline in sales and narrowing lossAnnual report

    「For the cumulative first quarter, the Group's consolidated net sales were ¥2,787.190 million, down 8.0% from the same quarter of the previous year. As a result, the company posted an operating loss of ¥212.472 million, compared with an operating loss of ¥387.277 million in the same quarter of the previous year; an ordinary loss of ¥212.896 million, compared with an ordinary loss of ¥387.606 million; and an income taxes adjustments amount of -¥79.664 million, resulting in a quarterly net loss attributable to owners of the parent of ¥140.692 million, compared with a quarterly net loss attributable to owners of the parent of ¥275.927 million.」

    While net sales declined 8.0% year on year, the operating loss narrowed from ¥387.277 million to ¥212.472 million, and the quarterly net loss attributable to owners of the parent narrowed from ¥275.927 million to ¥140.692 million.
  13. FY2022WorsenedAnnual report

    「For the fiscal year, the Group's consolidated net sales were ¥12,908.861 million. As a result, the company posted an operating loss of ¥316.730 million, an ordinary loss of ¥292.579 million and an income taxes adjustments amount of ¥36.971 million, resulting in a net loss attributable to owners of the parent of ¥269.030 million.」

    Net sales were ¥12,908.861 million, the operating loss was ¥316.730 million and the net loss attributable to owners of the parent was ¥269.030 million, representing a deterioration from operating income and net income in the previous fiscal year to full-year operating and net losses.
  14. FY2022-Q3WorsenedAnnual report

    「As a result, the company posted an operating loss of ¥505.010 million, an ordinary loss of ¥480.865 million and an income taxes adjustments amount of ¥25.222 million, resulting in a quarterly net loss attributable to owners of the parent of ¥529.325 million.」

    For the cumulative third quarter, net sales were ¥9,558.459 million, the operating loss was ¥505.010 million and the quarterly net loss attributable to owners of the parent was ¥529.325 million. The loss expanded from an operating loss of ¥147.780 million in the same period of the previous year, and the operating margin declined from -1.4% to -5.3%. The accounting treatment differs from that used in the same period of the previous year due to the adoption of the revenue recognition standard.
  15. FY2022-Q2WorsenedAnnual report

    「As a result, the company posted an operating loss of ¥568.334 million, an ordinary loss of ¥568.014 million and an income taxes adjustments amount of -¥42.314 million, resulting in a quarterly net loss attributable to owners of the parent of ¥464.481 million.」

    For the cumulative second quarter, the company posted an operating loss of ¥568.334 million, an ordinary loss of ¥568.014 million and a quarterly net loss attributable to owners of the parent of ¥464.481 million. Losses expanded from an operating loss of ¥320.022 million and a net loss of ¥201.854 million in the same period of the previous year. The operating margin also declined from -4.8% to -9.5%.
  16. FY2022-Q1WorsenedAnnual report

    「As a result, the company posted an operating loss of ¥387.277 million, an ordinary loss of ¥387.606 million and an income taxes adjustments amount of -¥95.961 million, resulting in a quarterly net loss attributable to owners of the parent of ¥275.927 million.」

    In the first quarter, the company posted an operating loss of ¥387.277 million, an ordinary loss of ¥387.606 million and a quarterly net loss attributable to owners of the parent of ¥275.927 million. Net sales were also ¥3,028.627 million, down from ¥3,223.478 million in the same period of the previous year. However, because the accounting treatment differs from that used in the same period of the previous year due to the adoption of the revenue recognition standard, the company has not stated year-on-year changes.
  17. FY2021WorsenedAnnual report

    「For the fiscal year, the Group's consolidated net sales were ¥14,307.709 million, down 22.1% from the previous fiscal year. As a result, operating income was ¥226.974 million, down 88.6%; ordinary income was ¥250.688 million, down 87.3%; and net income attributable to owners of the parent was ¥216.419 million, down 83.5%.」

    The company shifted from sales and profit growth in the previous fiscal year to lower sales and profits, with net sales down 22.1% and operating income down 88.6%. Sales of basic skincare products also declined 21.4% year on year.
  18. FY2021-Q3WorsenedAnnual report

    「For the cumulative third quarter, the Group's consolidated net sales were ¥10,332.029 million, down 26.6% year on year. As a result, the company posted an operating loss of ¥147.780 million, compared with operating income of ¥1,752.304 million in the same quarter of the previous year; an ordinary loss of ¥147.586 million, compared with ordinary income of ¥1,729.631 million; and a quarterly net loss attributable to owners of the parent of ¥87.081 million, compared with quarterly net income attributable to owners of the parent of ¥1,118.023 million.」

    For the cumulative third quarter, net sales declined 26.6% year on year, and the company shifted from operating, ordinary and quarterly net income to operating, ordinary and quarterly net losses. The operating margin also declined from 12.4% in the same period of the previous year to -1.4%.
  19. FY2021-Q2WorsenedAnnual report

    「As a result, the company posted an operating loss of ¥320.022 million, compared with operating income of ¥1,480.431 million in the same quarter of the previous year; an ordinary loss of ¥319.785 million, compared with ordinary income of ¥1,480.213 million; and a quarterly net loss attributable to owners of the parent of ¥201.854 million, compared with quarterly net income attributable to owners of the parent of ¥956.967 million.」

    For the cumulative second quarter, net sales were ¥6,653.244 million, down 30.2% year on year, and the company shifted from sales and profit growth in the same period of the previous year to operating, ordinary and quarterly net losses. The operating margin also declined from 15.5% to -4.8%.
  20. FY2021-Q1WorsenedAnnual report

    「For the cumulative first quarter, the Group's consolidated net sales were ¥3,223.478 million, down 28.4% year on year. As a result, the Group posted an operating loss of ¥309.225 million, compared with operating income of ¥673.711 million in the same quarter of the previous year; an ordinary loss of ¥308.395 million, compared with ordinary income of ¥673.408 million; and a quarterly net loss attributable to owners of the parent of ¥195.165 million, compared with quarterly net income attributable to owners of the parent of ¥428.977 million.」

    The company shifted from sales and profit growth in the same period of the previous year to a 28.4% decline in net sales and operating, ordinary and quarterly net losses. The operating margin also declined from 15.0% in the same period of the previous year to -9.6%.
  21. FY2020WorsenedAnnual report

    「For the fiscal year, the Group's consolidated net sales were ¥18,369.640 million, down 4.6% year on year. As a result, operating income was ¥1,997.873 million, down 35.4%; ordinary income was ¥1,975.966 million, down 36.3%; and net income attributable to owners of the parent was ¥1,313.475 million, down 37.1%.」

    For the full year, net sales declined 4.6% year on year and operating income declined 35.4%, marking a shift from sales and profit growth to lower sales and profits. The operating margin also fell from 16.1% in the previous fiscal year to 10.9%.
  22. FY2020-Q3WorsenedAnnual report

    「As a result, operating income was ¥1,752.304 million, down 4.5%; ordinary income was ¥1,729.631 million, down 6.1%; and net income attributable to owners of the parent was ¥1,118.023 million, down 7.8%.」

    Net sales were ¥14,084.613 million, up only 0.7% year on year, while operating income, ordinary income and quarterly net income were all below the previous year's levels. The operating margin also declined from 13.1% to 12.4%, marking a shift from the previous trend of sales and profit growth to lower profits.
  23. FY2020-Q2AdvancedAnnual report

    「For the cumulative second quarter, the Group's consolidated net sales were ¥9,532.387 million, up 7.5% year on year. As a result, operating income was ¥1,480.431 million, up 45.2%; ordinary income was ¥1,480.213 million, up 44.8%; and net income attributable to owners of the parent was ¥956.967 million, up 43.6%.」

    Sales and profit growth progressed during the cumulative second quarter. The operating margin improved by 4.0 percentage points, from 11.5% in the same period of the previous year to 15.5%.
  24. FY2020-Q1AdvancedAnnual report

    「As a result, operating income was ¥673.711 million, up 52.5%; ordinary income was ¥673.408 million, up 51.0%; and net income attributable to owners of the parent was ¥428.977 million, up 49.4%.」

    Sales and profit growth progressed during the cumulative first quarter. Net sales were ¥4,503.167 million, up 3.4% year on year, while the operating margin improved by 4.9 percentage points, from 10.1% in the same period of the previous year to 15.0%.
  25. FY2019AdvancedAnnual report

    「For the fiscal year, the Group's consolidated net sales were ¥19,253.557 million, up 7.6% year on year. As a result, operating income was ¥3,095.043 million, up 28.9%; ordinary income was ¥3,100.722 million, up 29.7%; and net income attributable to owners of the parent was ¥2,088.478 million, up 30.7%.」

    Full-year sales and profits increased, with net sales of ¥19,253.55 million, operating income of ¥3,095.04 million and an operating margin of 16.1%. Sales of basic skincare products also increased 6.6% year on year.
  26. FY2019-Q3AdvancedAnnual report

    「For the cumulative third quarter of the current consolidated fiscal year, the Group's consolidated net sales were ¥13,991,177 thousand, up 8.3% year on year. As a result, operating profit was ¥1,835,304 thousand, up 21.9%, ordinary profit was ¥1,841,411 thousand, up 22.9%, and profit attributable to owners of the parent was ¥1,213,263 thousand, up 23.5%.」

    The trend toward higher revenue and profit continued to develop during the cumulative third quarter. The operating margin improved by 1.4 percentage points, from 11.7% in the same period of the previous year to 13.1%, and sales of basic skincare products increased 7.8% year on year.
  27. FY2019-Q2AdvancedAnnual report

    「For the cumulative second quarter of the current consolidated fiscal year, the Group's consolidated net sales were ¥8,863,802 thousand, up 11.4% year on year. As a result, operating profit was ¥1,019,235 thousand, up 55.5%, ordinary profit was ¥1,022,528 thousand, up 57.4%, and profit attributable to owners of the parent was ¥666,361 thousand, up 61.5%.」

    The trend toward higher revenue and profit continued to develop during the cumulative second quarter. The operating margin improved by 3.3 percentage points, from 8.2% in the same period of the previous year to 11.5%, while sales of basic skincare products increased 12.0% year on year.
  28. FY2019-Q1AdvancedAnnual report

    「For the cumulative first quarter of the current consolidated fiscal year, the Group's consolidated net sales were ¥4,354,833 thousand, up 12.2% year on year. As a result, operating profit was ¥441,710 thousand, up 77.4%, ordinary profit was ¥446,021 thousand, up 79.9%, and profit attributable to owners of the parent was ¥287,109 thousand, up 88.3%.」

    The trend toward higher revenue and profit continued to develop during the cumulative first quarter. Net sales increased 12.2% and operating profit increased 77.4%, while the operating margin improved by 3.7 percentage points, from 6.4% in the same period of the previous year to 10.1%. Sales of basic skincare products increased 13.1% year on year.
  29. FY2018AdvancedAnnual report

    「For the current consolidated fiscal year, the Group's consolidated net sales were ¥17,885,688 thousand, up 10.8% year on year. As a result, operating profit was ¥2,400,257 thousand, up 35.6%, ordinary profit was ¥2,390,194 thousand, up 36.7%, and profit attributable to owners of the parent was ¥1,597,847 thousand, up 31.7%.」

    Revenue and profit both increased for the full year, with net sales of ¥17,885.68 million, operating profit of ¥2,400.25 million and an operating margin of 13.4%. Sales of basic skincare products also increased 15.7% year on year.
  30. FY2018-Q3AdvancedAnnual report

    「For the cumulative third quarter of the current consolidated fiscal year, the Group's consolidated net sales were ¥12,920,371 thousand, up 12.7% year on year. As a result, operating profit was ¥1,505,669 thousand, up 45.8%, ordinary profit was ¥1,497,889 thousand, up 47.8%, and profit attributable to owners of the parent was ¥982,178 thousand, up 51.7%.」

    The trend toward higher revenue and profit continued to develop during the cumulative third quarter. Sales of basic skincare products were ¥9,314,692 thousand, up 17.0% year on year, and sales of makeup products were ¥973,946 thousand, up 0.8%.
  31. FY2018-Q2AdvancedAnnual report

    「For the cumulative second quarter of the current consolidated fiscal year, the Group's consolidated net sales were ¥7,959,973 thousand, up 9.8% year on year. As a result, operating profit was ¥655,384 thousand, up 13.9%, ordinary profit was ¥649,789 thousand, up 16.1%, and profit attributable to owners of the parent was ¥412,602 thousand, up 12.7%.」

    The trend toward higher revenue and profit continued to develop during the cumulative second quarter. Sales of basic skincare products were ¥5,835,169 thousand, up 14.1% year on year, while sales of makeup products were ¥566,027 thousand, down 2.3%.
  32. FY2018-Q1AdvancedAnnual report

    「As a result, operating profit was ¥248,969 thousand, up 38.7% year on year, ordinary profit was ¥247,885 thousand, up 48.1%, and profit attributable to owners of the parent was ¥152,475 thousand, up 63.9%.」

    The trend toward higher revenue and profit also advanced during the cumulative first quarter. Net sales were ¥3,882,856 thousand, up 15.5% year on year, and sales of basic skincare products were ¥2,813,790 thousand, up 17.5%.
  33. FY2017-Q3AdvancedAnnual report

    「For the cumulative third quarter of the current consolidated fiscal year, the Group's consolidated net sales were ¥11,468,434 thousand, up 12.3% year on year.」

    The trend toward higher revenue and profit continued to develop through the cumulative third quarter. Operating profit was ¥1,032,575 thousand, up 134.2% year on year, ordinary profit was ¥1,013,357 thousand, up 119.0%, and profit attributable to owners of the parent was ¥647,599 thousand, up 96.4%. Sales of basic skincare products were ¥7,958,510 thousand, up 20.4%, and sales of makeup products were ¥965,782 thousand, up 22.4%.
  34. FY2017-Q2First statedAnnual report

    「For the cumulative second quarter of the current consolidated fiscal year, the Group's consolidated net sales were ¥7,252,284 thousand, up 17.3% year on year. As a result, operating profit was ¥575,276 thousand, ordinary profit was ¥559,580 thousand and profit attributable to owners of the parent was ¥365,996 thousand.」

    The Company recorded operating profit, ordinary profit and profit attributable to owners of the parent for the cumulative second quarter of the current fiscal year, compared with operating loss, ordinary loss and quarterly net loss in the same period of the previous year. By product category, sales of basic skincare products increased 27.4% year on year, while sales of makeup products increased 35.7%.
Moved together

"Impact of COVID-19 on Demand and Business Activities" moved the same way as this thread, in the same document, in 9 of its 36 moves.

985554★123456
  1. ★This thread
  2. 1Impact of COVID-19 on Demand and Business Activities9×
  3. 2Implementation of a new core business system8×
  4. 3Joint research and development of high-function products centered on the Life Science Research Institute5×
  5. 4Supplement production and support for small-lot, high-mix OEM manufacturing5×
  6. 5Improving delivery efficiency through a two-location network in eastern and western Japan5×
  7. 6Achieving stable growth over the medium to long term4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Haba Laboratories's next results are scheduled for 2026-11-13. Read the earnings preview It last moved in the Results of 2026-11-13: "Worsened".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.